Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed May 20, 2016
Insider Transaction Report
Form 4
Freve Jonathan
CFO, Treasurer & Secretary
Transactions
- Award
Stock Option (right to buy)
2016-05-19+17,209→ 17,209 totalExercise: $10.97Exp: 2026-05-18→ Common Stock (17,209 underlying)
Footnotes (1)
- [F1]This option was granted on May 19, 2016, with 25% of the shares subject to the option vesting on January 1, 2017 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.